BALAXI PHARMACEUTICALS LIMITED Asset Resilience Ratio

Latest as of March 2025: 0.42%

BALAXI PHARMACEUTICALS LIMITED asset resilience ratio. BALAXI PHARMACEUTICALS LIMITED (BALAXI) has an Asset Resilience Ratio of 0.42% as of March 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See BALAXI PHARMACEUTICALS LIMITED defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.

Liquid Assets

Rs13.04 Million

≈ $140.98K USD Cash + Short-term Investments

Total Assets

Rs3.10 Billion

≈ $33.56 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of BALAXI PHARMACEUTICALS LIMITED (2013–2025)

Asset resilience ratio of BALAXI PHARMACEUTICALS LIMITED from 2013 to 2025. This chart shows how BALAXI PHARMACEUTICALS LIMITED's Asset Resilience Ratio has changed over time. Read BALAXI liabilities breakdown for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down BALAXI PHARMACEUTICALS LIMITED's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see BALAXI PHARMACEUTICALS LIMITED assets under control.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Rs0.00	0%
Short-term Investments	Rs13.04 Million	0.42%
Total Liquid Assets	Rs13.04 Million	0.42%

Asset Resilience Insights

Limited Liquidity: BALAXI PHARMACEUTICALS LIMITED maintains only 0.42% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

BALAXI PHARMACEUTICALS LIMITED Industry Peers by Asset Resilience Ratio

Compare BALAXI PHARMACEUTICALS LIMITED's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Jiangsu Hengrui Medicine Co Ltd SHG:600276	Drug Manufacturers - Specialty & Generic	0.16%
Sandoz Group AG SW:SDZ	Drug Manufacturers - Specialty & Generic	7.89%
H Lundbeck A/S CO:HLUN-B	Drug Manufacturers - Specialty & Generic	-0.56%
Changchun High & New Technology Industries Group Inc SHE:000661	Drug Manufacturers - Specialty & Generic	5.50%
Hubei Jumpcan Pharmaceutical Co Ltd SHG:600566	Drug Manufacturers - Specialty & Generic	47.16%
Kangmei Pharmaceutical Co Ltd SHG:600518	Drug Manufacturers - Specialty & Generic	0.00%
Viyash Scientific Limited NSE:SEQUENT	Drug Manufacturers - Specialty & Generic	0.08%
Anhui Fengyuan Pharmaceutical Co Ltd SHE:000153	Drug Manufacturers - Specialty & Generic	1.81%

BALAXI PHARMACEUTICALS LIMITED Asset Resilience Ratio by Year (2013–2025)

BALAXI PHARMACEUTICALS LIMITED asset resilience ratio by year from 2013 to 2025. The table below shows the annual Asset Resilience Ratio data for BALAXI PHARMACEUTICALS LIMITED.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-03-31	0.42%	Rs13.04 Million ≈ $140.98K	Rs3.10 Billion ≈ $33.56 Million	+0.42pp
2024-03-31	0.00%	Rs1.00K ≈ $10.81	Rs2.58 Billion ≈ $27.94 Million	-4.18pp
2022-03-31	4.18%	Rs73.77 Million ≈ $797.82K	Rs1.76 Billion ≈ $19.08 Million	-6.94pp
2020-03-31	11.12%	Rs40.01 Million ≈ $432.66K	Rs359.71 Million ≈ $3.89 Million	+8.94pp
2019-03-31	2.18%	Rs1.33 Million ≈ $14.38K	Rs61.08 Million ≈ $660.54K	--
2018-03-31	0.00%	Rs0.00 ≈ $0.00	Rs16.87 Million ≈ $182.41K	--
2017-03-31	-0.04%	Rs-11.50K ≈ $-124.37	Rs25.77 Million ≈ $278.65K	-1.27pp
2014-03-31	1.23%	Rs148.09K ≈ $1.60K	Rs12.04 Million ≈ $130.21K	+1.03pp
2013-03-31	0.20%	Rs25.00K ≈ $270.37	Rs12.38 Million ≈ $133.91K	--

pp = percentage points

About BALAXI PHARMACEUTICALS LIMITED

NSE:BALAXI India Drug Manufacturers - Specialty & Generic

Market Cap

$12.24 Million

Rs1.13 Billion INR

Market Cap Rank

#26387 Global

#1468 in India

Share Price

Rs20.50

Change (1 day)

+1.18%

52-Week Range

Rs15.67 - Rs42.26

All Time High

Rs207.74